Therapeutic Advances for Patients With Chronic Lymphocytic Leukemia

home / insights / therapeutic-advances-for-patients-with-chronic-lymphocytic-leukemia

This OncLive Insights features 3 experts who elucidate treatment advances for patients with Chronic Lymphocytic Leukemia (CLL). Considering both the frontline and relapsed/refractory setting, these key opinion leaders share their perspectives on optimal risk stratification, molecular targets, and sequencing strategies given data from recent clinical trials.